Placeholder Banner

BIO Comments to FDA on their Workshop to Enhance Clinical Study Diversity

January 29, 2024

Following the FDA Workshop to Enhance Clinical Study Diversity on November 29-30, 2023, BIO submits specific comments per the request for information (FDA-2023-N-2462).

Download Full Comments Below
bio_comment_letter_-_fda-2023-n-2462_-_clinical_study_diversity_workshop.pdf
Discover More
In response to the request for information and comments, BIO submitted general comments and recommended edits (FDA-2017-D-6530)
In response to the request for information and comments, BIO submitted general comments and recommended edits (FDA-2023-D-2318)
BIO provided general comments and recommended edits Re: FDA-2023-D-3031